Serum amyloid A

Serum amyloid A (SAA) is an acute phase protein upregulated in the liver after traumatic brain injury (TBI). So far, it has not been investigated whether SAA expression also occurs in the brain in response to TBI. For this, we performed a moderate controlled cortical impact injury in adult male and female mice and analyzed brain, blood, and liver samples at 6 h, 1, 3, and 10 days post-injury (dpi). We measured the levels of SAA in serum, brain and liver by western blot. We also used immunohistochemical techniques combined with in situ hybridization to determine SAA mRNA and protein expression in the brain. Our results revealed higher levels of SAA in the bloodstream in males compared to females at 6 h post-TBI. Liver and serum SAA protein showed a peak of expression at 1 dpi followed by a decrease at 3 to 10 dpi in both sexes. Both SAA mRNA and protein expression colocalize with astrocytes and macrophages/microglia in the cortex, corpus callosum, thalamus, and hippocampus after TBI. For the first time, here we show that SAA is expressed in the brain in response to TBI. Collectively, SAA expression was higher in males compared to females, and in association with the sex-dependent neuroinflammatory response after brain injury. We suggest that SAA could be a crucial protein associated to the acute neuroinflammation following TBI, not only for its hepatic upregulation but also for its expression in the injured brain ¹⁾.

2: Ozaki T, Muramatsu R, Nakamura H, Kinoshita M, Kishima H, Yamashita T. Proteomic analysis of protein changes in plasma by balloon test occlusion. J Clin Neurosci. 2020 Feb;72:397-401. doi: 10.1016/j.jocn.2019.12.005. Epub 2019 Dec 23. PubMed PMID: 31875829.

3: Wicker E, Benton L, George K, Furlow W, Villapol S. Serum Amyloid A Protein as a Potential Biomarker for Severity and Acute Outcome in Traumatic Brain Injury. Biomed Res Int. 2019 Apr 16;2019:5967816. doi: 10.1155/2019/5967816. eCollection 2019. PubMed PMID: 31119176; PubMed Central PMCID: PMC6500682.

4: Kurvits L, Reimann E, Kadastik-Eerme L, Truu L, Kingo K, Erm T, Kõks S, Taba P, Planken A. Serum Amyloid Alpha Is Downregulated in Peripheral Tissues of Parkinson's Disease Patients. Front Neurosci. 2019 Jan 29;13:13. doi: 10.3389/fnins.2019.00013. eCollection 2019. PubMed PMID: 30760975; PubMed Central PMCID: PMC6361740.

5: Lin CY, Yang ST, Shen SC, Hsieh YC, Hsu FT, Chen CY, Chiang YH, Chuang JY, Chen KY, Hsu TI, Leong WC, Su YK, Lo WL, Yeh YS, Patria YN, Shih HM, Chang CC, Chou SY. Serum amyloid A1 in combination with integrin αVβ3 increases glioblastoma cells mobility and progression. Mol Oncol. 2018 May;12(5):756-771. doi: 10.1002/1878-0261.12196. Epub 2018 Apr 17. PubMed PMID: 29603594; PubMed Central PMCID: PMC5928363.

6: Azurmendi L, Degos V, Tiberti N, Kapandji N, Sanchez P, Sarrafzadeh A, Puybasset L, Turck N, Sanchez JC. Measuring Serum Amyloid A for Infection Prediction in Aneurysmal Subarachnoid Hemorrhage. J Proteome Res. 2015 Sep 4;14(9):3948-56. doi: 10.1021/acs.jproteome.5b00391. Epub 2015 Aug 24. PubMed PMID: 26198378.

7: Jang SY, Shin YK, Lee HY, Park JY, Suh DJ, Kim JK, Bae YS, Park HT. Local production of serum amyloid a is implicated in the induction of macrophage chemoattractants in Schwann cells during wallerian degeneration of peripheral nerves. Glia. 2012 Oct;60(10):1619-28. doi: 10.1002/glia.22382. Epub 2012 Jul 9. PubMed PMID: 22777957.

8: Wu X, Mimms R, Lima R, Peters-Hall J, Rose MC, Peña MT. Localization of inflammatory mediators in pediatric sinus mucosa. Arch Otolaryngol Head Neck Surg. 2012 Apr;138(4):389-97. doi: 10.1001/archoto.2012.155. PubMed PMID: 22508623; PubMed Central PMCID: PMC4497780.

9: Wu X, Ghimbovschi S, Aujla PK, Rose MC, Peña MT. Expression profiling of inflammatory mediators in pediatric sinus mucosa. Arch Otolaryngol Head Neck Surg. 2009 Jan;135(1):65-72. doi: 10.1001/archoto.2008.505. PubMed PMID: 19153309; PubMed Central PMCID: PMC2696810.